High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome

Anne-Sophie Chretien, Raynier Devillier, Samuel Granjeaud, Charlotte Cordier, Clemence Demerle, Nassim Salem, Julia Wlosik, Florence Orlanducci, Laurent Gorvel, Stephane Fattori, Marie-Anne Hospital, Jihane Pakradouni, Emilie Gregori, Magali Paul, Philippe Rochigneux, Thomas Pagliardini, Mathieu Morey, Cyril Fauriat, Nicolas Dulphy, Antoine Toubert, Herve Luche, Marie Malissen, Didier Blaise, Jacques A. Nunès, Norbert Vey, Daniel Olive

Open source

DOI
10.1073/pnas.2020459118
Published
2021-05-28
Container
Proceedings of the National Academy of Sciences
Publisher
National Academy of Sciences
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1073/pnas.2020459118,
  title = {High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome},
  author = {Anne-Sophie Chretien and Raynier Devillier and Samuel Granjeaud and Charlotte Cordier and Clemence Demerle and Nassim Salem and Julia Wlosik and Florence Orlanducci and Laurent Gorvel and Stephane Fattori and Marie-Anne Hospital and Jihane Pakradouni and Emilie Gregori and Magali Paul and Philippe Rochigneux and Thomas Pagliardini and Mathieu Morey and Cyril Fauriat and Nicolas Dulphy and Antoine Toubert and Herve Luche and Marie Malissen and Didier Blaise and Jacques A. Nunès and Norbert Vey and Daniel Olive},
  year = {2021},
  journal = {Proceedings of the National Academy of Sciences},
  doi = {10.1073/pnas.2020459118},
  url = {https://doi.org/10.1073/pnas.2020459118}
}

RIS

TY  - JOUR
TI  - High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome
AU  - Anne-Sophie Chretien
AU  - Raynier Devillier
AU  - Samuel Granjeaud
AU  - Charlotte Cordier
AU  - Clemence Demerle
AU  - Nassim Salem
AU  - Julia Wlosik
AU  - Florence Orlanducci
AU  - Laurent Gorvel
AU  - Stephane Fattori
AU  - Marie-Anne Hospital
AU  - Jihane Pakradouni
AU  - Emilie Gregori
AU  - Magali Paul
AU  - Philippe Rochigneux
AU  - Thomas Pagliardini
AU  - Mathieu Morey
AU  - Cyril Fauriat
AU  - Nicolas Dulphy
AU  - Antoine Toubert
AU  - Herve Luche
AU  - Marie Malissen
AU  - Didier Blaise
AU  - Jacques A. Nunès
AU  - Norbert Vey
AU  - Daniel Olive
PY  - 2021
JO  - Proceedings of the National Academy of Sciences
DO  - 10.1073/pnas.2020459118
UR  - https://doi.org/10.1073/pnas.2020459118
ER  - 

APA

Chretien, A., Devillier, R., Granjeaud, S., Cordier, C., Demerle, C., Salem, N., Wlosik, J., Orlanducci, F., Gorvel, L., Fattori, S., Hospital, M., Pakradouni, J., Gregori, E., Paul, M., Rochigneux, P., Pagliardini, T., Morey, M., Fauriat, C., Dulphy, N., Toubert, A., Luche, H., Malissen, M., Blaise, D., Nunès, J. A., Vey, N., & Olive, D. (2021). High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2020459118

Source records